CG vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CG

59.3
AI Score
VS
CG Wins

CNS

55.5
AI Score

Investment Advisor Scores

CG

59score
Recommendation
HOLD

CNS

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CG CNS Winner
Forward P/E 10.9529 22.9358 CG
PEG Ratio 0.9695 2.0481 CG
Revenue Growth -94.1% 12.2% CNS
Earnings Growth 70.2% 31.9% CG
Tradestie Score 59.3/100 55.5/100 CG
Profit Margin 16.8% 28.8% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CG 1M: +8.7% · 3M: -8.1% CNS 1M: +6.3% · 3M: +17.0%

Current Technical Phase

CG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.4 · Price: $46.02

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 60

RSI (14): 60.3 · Price: $82.27

Fundamentals Snapshot

Metric CG CNS
Market Cap
Forward P/E 9.0 21.2
Trailing P/E 31.1 25.1
Revenue (TTM)
Revenue Growth -0.9% 0.1%
Gross Margin 0.9% 0.5%
Operating Margin -2.3% 0.3%
EPS 1.46 3.25
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.